Jane Pruemer , PharmD

Jane Pruemer, PharmD, BCOP, FASHP, is currently Professor Emerita of Clinical Pharmacy Practice at the James L. Winkle Cincinnati College of Pharmacy, University of Cincinnatii. Dr. Pruemer received a BS in Pharmacy from the St. Louis College of Pharmacy and a PharmD from the University of Kentucky College of Pharmacy. She completed an American Society of Health-System Pharmacists (ASHP)–accredited residency in clinical pharmacy from the Hospital of the University of Pennsylvania and a fellowship in pharmacokinetics/oncology at the Philadelphia College of Pharmacy and Sciences. Dr. Pruemer had an active clinical adult oncology practice and was the founding program director for an ASHP-accredited specialty residency in oncology pharmacy practice at the University of Cincinnati Medical Center Hospital. Dr. Pruemer has held various offices and served on several committees for national and state pharmacy associations, including the ASHP Oncology Specialty Practice Group. She was a member of the Advisory Board and Interim Executive Committee for ASHP’s Section of Clinical Specialists and served on the Commission on Credentialing as its Chairman. She was a member of the Oncology Pharmacy Specialty Council of the Board of Pharmaceutical Specialties. She was also on the Executive Board of the Hematology/Oncology Pharmacy Association, and serves on the HOPA Nominatons Committee. Her primary research interest was the supportive care of cancer patients.

Pharmacotherapy of cancer. Supportive care of cancer patients. Quality of life in cancer patients.

Investigators:Dr. Thomas S. Webb, PI 2007 -2011 Health Resources and Services Administration (HRSA) Cincinnati Sickle Cell Care Network Role:Consultant $1,280,000 Active Type:Grant Level:National

Investigators:J Pruemer and S Buring 2007 -2008 Hamilton County Health Department/Ohio Tobacco Use Prevention and Control Foundation Smoking Cessation Program: Win by Quitting Funding Requested: Length of funding requested: 1 year Role:PI $30,870 (In-Kind Match of $2,260) Total Grant = $33,130.00 Completed Level:State

Grant: #C4130555 Investigators:Guo, Jianfei; Pruemer, Jane 04-01-2011 -04-30-2014 Genentech, Inc. Treatment Patterns Among Patients with Gastric Cancer in China and USA Role:Collaborator $55,881.00 Active Level:Industry

Published Abstracts

Sweany SJ, LaFollette JA, Pruemer J, Nahleh Z. (2007. ) Effect of melatonin on taxane-induced neuropathy in breast cancer patients. .[Abstract]J Clin Oncol (Pro ASCO):A19640, 718S.Co-Author

Roddy J, Partridge S, Rockey M, Pruemer J, Guo J, Desai S, and Safa M. (2008. ) Incidence of Thromboembolic Events in Colorectal Cancer Patients Receiving the Combination of Bevacizumab-based Chemotherapy and Erythropoietin Stimulating Agents .[Abstract]J Clin Oncol, Co-Author

Peer Reviewed Publications

Roddy, Julianna V F; Partridge, Suzanne M; Rockey, Michelle L; Pruemer, Jane M; Guo, Jeff J; Desai, Shaili J; Safa, Malek M (2010. ) Thromboembolic events in patients with colorectal cancer receiving the combination of bevacizumab-based chemotherapy and erythropoietin stimulating agents.American journal of clinical oncology, , 33 (1 ) ,36-42 More Information

Whitmer, Kyra M; Pruemer, Jane M; Nahleh, Zeina A; Jazieh, Abdul R (2006. ) Symptom management needs of oncology outpatients.Journal of palliative medicine, , 9 (3 ) ,628-30 More Information

Pruemer, Jane M; Teeters, Janet L (2004. ) Improving pharmacy residency training. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, , 61 (23 ) ,2504

Cohen, M R; Anderson, R W; Attilio, R M; Green, L; Muller, R J; Pruemer, J M (1996. ) Preventing medication errors in cancer chemotherapy. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, , 53 (7 ) ,737-46

Chapman, S M; Pruemer, J M (1993. ) Ondansetron use in a major university teaching hospital. American journal of hospital pharmacy, , 50 (4 ) ,670-4

Breneman, D L; Nartker, A L; Ballman, E A; Pruemer, J M; Blumsack, R F; Davis, M; Breneman, J C (1991. ) Topical mechlorethamine in the treatment of mycosis fungoides. Uniformity of application and potential for environmental contamination. Journal of the American Academy of Dermatology, , 25 (6 Pt 1 ) ,1059-64

Woloschuk, D M; Wermeling, J R; Pruemer, J M (1991. ) Stability and compatibility of fluorouracil and mannitol during simulated Y-site administration. American journal of hospital pharmacy, , 48 (10 ) ,2158-60

Wermeling, J R; Pruemer, J M; Hassan, F M; Warner, A; Pesce, A J (1989. ) Liquid-chromatographic monitoring of cytosine arabinoside and its metabolite, uracil arabinoside, in serum. Clinical chemistry, , 35 (6 ) ,1011-5

Woloschuk, D M; Pruemer, J M; Cluxton, R J (1988. ) Carboplatin: a new cisplatin analog. Drug intelligence & clinical pharmacy, , 22 (11 ) ,843-9

Dede, Ruth J; Pruemer, Jane M (2016. ) Comparing venous thromboembolism prophylactic strategies for ambulatory multiple myeloma patients on immunomodulatory drug therapy.Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, , 22 (2 ) ,248-55 More Information

Book Chapter

Pruemer JM and Rockey ML. (2008 ) Pharmacotherapy: A Patient-Focused Approach “Non-Small Cell Lung Cancer” .Stamford, CT, Appleton & Lange (Co-Author)

Pruemer J. (2008 ) Cardiovascular Toxicology, Fourth Edition Cardiotoxocity of Anthracyclines and Other Antineoplastic Agents .London and New York, Taylor & Francis

Pruemer JM and Rockey ML (2008 ) Pancreatic Cancer Cancer Pain and Symptom Management-Drug Therapy .New York, NY, Springer

Poon B, Witmer C, and Pruemer J (2013 ) Coagulation Disorders Pharacotherapy: A Pathophysiologic Approach, Nineth Edition .New York, NY, McGraw Hill Medical (Co-Author)

Poster Presentations

Hendricks J, Pruemer J, Whitmer K, McCaig L, Wilhelm C, Hester J. (2008. ) (Under Review. ) Quantifying Patient-Reported Outcomes Among Patients Treated for Cancer-related Pain at a Multidisciplinary Symptom Management Clinic .ACCP, Louisville, KY. . Professional Meeting. . Level:National

Thrombosis and Haemostasis Peer Review/Referee Level:International 2006 -2008

Hematology/Oncology Pharmacy Association (BCOP Recertification Committee ) Committee Member Level:National 2007 -2008

Hematology/Oncology Pharmacy Association (Executive Board ) Board Member Level:National 2008 -2010

Oncology Pharmacy,Supportive Care,Antineoplastic Therapy,Quality of Life,Pharmacoeconomics,Pharmacokinetics,Pain Management

Academic - University of Cincinnati College of Pharmacy
Wherry Hall, Room 306B
Phone: 513-558-6874
Jane.Pruemer@uc.edu